Contributed Equity

12 Months Ended

Jun. 30, 2026

NOTE 23. CONTRIBUTED EQUITY


				Consolidated
				June 30, 2026		June 30, 2025
	Note			A$		A$
Fully paid ordinary shares		23	(a)		537,990,227		535,069,876
Options over ordinary shares – listed					9,661,954		9,661,954

					547,652,181		544,731,830

(a) Ordinary Shares


				June 30, 2026				June 30, 2025
	Note			No.		A$		No.		A$
At the beginning of reporting period					1,460,389,575		535,069,876		1,452,612,290		532,443,233
Exercise of performance rights (shares issued during the year)		23	(b)		5,856,523		1,804,155		7,777,285		2,626,643
Conversion of Convertible Notes (shares issued during the period)		23	(b)		7,441,304		1,116,196		—		—
Conversion of Warrants		23	(b)		33,904		—		—		—

At reporting date					1,473,721,306		537,990,227		1,460,389,575		535,069,876

(b) Shares issued


2026 Details	Number		Issue Price A$		Total A$
Conversion of Convertible Notes		7,441,304		0.15		1,116,196
Conversion of Warrants		33,904		—		—
Performance rights exercised (transfer from share-based payment reserve)		5,856,523		0.31		1,804,155

Total		13,331,731				2,920,351


2025 Details	Number		Issue Price A$		Total A$
Performance rights exercised (transfer from share-based payment reserve)		7,777,285		0.34		2,626,643

Total		7,777,285				2,626,643

Ordinary shares

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held.

The fully paid ordinary shares have no par value and the company does not have a limited amount of authorized capital.

On a show of hands every member present at a meeting in person or by proxy shall have one vote and upon a poll each share shall have one vote.

Options

Information relating to the Company’s Executive Incentive Plan, including details of options issued, exercised and lapsed during the year and options outstanding at the end of the reporting period, is set out in note 35.

Unlisted options

There were no unlisted options on issue as at June 30, 2026. The balance as at June 30, 2025 is set out in the table below.


Expiration Date	Exercise Price		Number
August 4, 2025	$	0.24		847,600

Total				847,600

buy-back

There is no current

on-market

buy-back.

Capital risk management

The consolidated entity’s objectives when managing capital are to safeguard its ability to continue as a going concern, so that the entity can continue to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital.

In order to maintain or adjust the capital structure, the consolidated entity may return capital to shareholders, and or issue new shares.

The consolidated entity would look to raise capital when an opportunity to invest in a business or company was seen as value adding relative to the current parent entity’s share price at the time of the investment. The consolidated entity is not actively pursuing additional investments in the short term as it continues to grow its existing businesses